by Pete Celano | Jun 22, 2025 | Uncategorized
In alignment with CDC’s Division of Viral Hepatitis 2025 Strategic Plan, the Viral Hepatitis National Progress Report provides information on progress toward 2025 goals for new viral hepatitis infections and viral hepatitis-related deaths, overall and for key...
by Pete Celano | Jun 20, 2025 | Uncategorized
Follow the progress of the bill here: https://www.govtrack.us/congress/bills/119/s1941
by Pete Celano | Jun 14, 2025 | Uncategorized
Here’s a breakdown of the nine (9) late‑stage MASH (metabolic dysfunction‑associated steatohepatitis) candidates from BioSpace’s article, summarized by each medication: 🔹 1. Survodutide (Boehringer Ingelheim) A dual GLP‑1/GIP receptor agonist currently in Phase III...
by Pete Celano | Jun 12, 2025 | Uncategorized
Honoring one the great original innovators in Hepatology: Dame Sheila Patricia Violet Sherlock (1918–2001) was a pioneering British physician widely regarded as the founder of modern hepatology—the study of liver diseases. Her career transformed liver medicine through...
by Pete Celano | Jun 1, 2025 | Uncategorized
From the superb writer Wayne Eskridge of the Fatty Liver Foundation:”When we look at the success of modern medicine and track the change in death rate for major diseases over time, a tragedy becomes clear. Since 1970, medicine has slowly been winning against...
